Many patients would not be able to complete their childhood without the life-changing therapies in development at Andelyn Biosciences. By manufacturing gene therapies for clients worldwide, Andelyn is providing cures and hope for families looking for a healthy future.
Andelyn Biosciences was born out of Nationwide Children's Hospital and continues to have a close relationship with its world-class Abigail Wexner Research Institute.
The name “Andelyn” was chosen to pay tribute to two patients that participated in pivotal clinical trials at Nationwide Children's. Their combined names serve as a reminder that while Andelyn is a biotech business, the patient is always first.